AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17505450 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy
Number of subjects: 400
Study 17505450 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy
Number of subjects: 400
Study 15551351 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg)
Number of subjects: 370
Study 15551351 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 370
Study 15551351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study 12046308 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy in juvenile glaucoma group (Group I)
Number of subjects: 32
Study 12046308 — intervention group
Group type: EXPERIMENTAL
Intervention: Juvenile glaucoma suspect group (Group II)
Number of subjects: 32
Study 12046308 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group III)
Number of subjects: 32
Study 7878390 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin spray
Number of subjects: 35
Study 7878390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 3067322 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms/kg ivermectin
Number of subjects: 0
Study 3067322 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms/kg ivermectin
Number of subjects: 0
Study 3067322 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms/kg ivermectin
Number of subjects: 0
Study 3067322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30912578 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected FFR (cFFR) for distal left anterior descending (LAD) artery
Number of subjects: 100
Study 30912578 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected FFR (cFFR) for distal circumflex (Cx) artery
Number of subjects: 100
Study 30912578 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected FFR (cFFR) for distal right coronary artery-posterior left ventricular artery (RCA-PLV)
Number of subjects: 100
Study 30912578 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected FFR (cFFR) for distal RCA-posterior descending artery (PDA)
Number of subjects: 100
Study 31640455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotus valve
Number of subjects: 912
Study 31640455 — intervention group
Group type: COMPARATOR
Intervention: CoreValve
Number of subjects: 912
Study 31640455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker dependent
Number of subjects: 912
Study 31640455 — intervention group
Group type: EXPERIMENTAL
Intervention: Not pacemaker dependent
Number of subjects: 912
Study 31640455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker dependency
Number of subjects: 912
Study 28935140 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Allulose (5 g)
Number of subjects: 13
Study 28935140 — intervention group
Group type: COMPARATOR
Intervention: Aspartame (10 mg)
Number of subjects: 13
Study 25451582 — intervention group
Group type: EXPERIMENTAL
Intervention: Advergame promoting energy-dense snacks
Number of subjects: 92
Study 25451582 — intervention group
Group type: COMPARATOR
Intervention: Advergame promoting nonfood products
Number of subjects: 92
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS-Flex mobile
Number of subjects: 74
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS-Flex fixed
Number of subjects: 74
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS mobile
Number of subjects: 74
Study 24088976 — intervention group
Group type: COMPARATOR
Intervention: LPS fixed
Number of subjects: 74
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative flexion
Number of subjects: 74
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Society Score
Number of subjects: 74
Study 24088976 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Society Score function
Number of subjects: 74
Study 22117659 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D‐3 supplementation of 400 IU/day
Number of subjects: 52
Study 22117659 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented group
Number of subjects: 52
Study 22117659 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D‐3 supplementation
Number of subjects: 52
Study 19329824 — intervention group
Group type: EXPERIMENTAL
Intervention: FAS/Partial FAS
Number of subjects: 0
Study 19329824 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Encephalopathy/Alcohol Exposed (SE/AE)
Number of subjects: 0
Study 19329824 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurobehavioral Disorder/Alcohol Exposed (ND/AE)
Number of subjects: 0
Study 19329824 — intervention group
Group type: COMPARATOR
Intervention: Healthy peers with no prenatal alcohol exposure
Number of subjects: 0
Study 16775813 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude stevioside 3.75 mg/kg/day (7 weeks), 7.5 mg/kg/day (11 weeks), 15.0 mg/kg/day (6 weeks)
Number of subjects: 0
Study 16775813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15286068 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management training for community mental health nurses
Number of subjects: 120
Study 15286068 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 120
Study 11736893 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro cytotoxicity model using HaCaT cells with various irritants (100 µL of 20 mmol L(‐1) aqueous solution)
Number of subjects: 0
Study 11736893 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo irritation potential in humans after 24-hour application of the same compounds
Number of subjects: 0
Study 9403904 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-disciplinary community team
Number of subjects: 0
Study 9403904 — intervention group
Group type: COMPARATOR
Intervention: Traditional psychiatric service
Number of subjects: 0
Study 8277130 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy interventions
Number of subjects: 2524
Study 8277130 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 2524
Study 3147905 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (12 g orally)
Number of subjects: 10
Study 3147905 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (3 x 12 g daily for 4 weeks)
Number of subjects: 10
Study 3147905 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (acute and chronic administration)
Number of subjects: 10
Study 30095504 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-duration isometric knee extension loading (24 sets of 10 seconds)
Number of subjects: 16
Study 30095504 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-duration isometric knee extension loading (6 sets of 40 seconds)
Number of subjects: 16
Study 31375043 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-Free Single Crutch (HFSC)
Number of subjects: 44
Study 31375043 — intervention group
Group type: COMPARATOR
Intervention: Standard Axillary Crutches (SACs)
Number of subjects: 44
Study 28425029 — intervention group
Group type: COMPARATOR
Intervention: AAFP 500 mg
Number of subjects: 56
Study 28425029 — intervention group
Group type: COMPARATOR
Intervention: AAFP 100 mg, 200 mg, 400 mg
Number of subjects: 56
Study 28425029 — intervention group
Group type: COMPARATOR
Intervention: AAFP 125 mg, 500 mg, 625 mg
Number of subjects: 56
Study 28425029 — intervention group
Group type: COMPARATOR
Intervention: OAA 1000 mg
Number of subjects: 56
Study 25318481 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg BID
Number of subjects: 15526
Study 25318481 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg BID
Number of subjects: 15526
Study 25318481 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (both doses combined)
Number of subjects: 15526
Study 25318481 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 15526
Study 25318481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15526
Study 23551798 — intervention group
Group type: EXPERIMENTAL
Intervention: Group assertiveness training (12 sessions)
Number of subjects: 74
Study 23551798 — intervention group
Group type: COMPARATOR
Intervention: Supportive control group
Number of subjects: 74
Study 21114586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 242
Study 21114586 — intervention group
Group type: COMPARATOR
Intervention: PEG-interferon
Number of subjects: 242
Study 18926940 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline mineral water (water B) rich in bicarbonate (per litre: 547 mg Ca, 2172 mg HCO(3)(‐), 9 mg SO(4)(‐), PRAL ‐11.2 mEq)
Number of subjects: 30
Study 18926940 — intervention group
Group type: COMPARATOR
Intervention: Acid calcium-rich water (water A) (per litre: 520 mg Ca, 291 mg HCO(3)(‐), 1160 mg SO(4)(‐), PRAL +9.2 mEq)
Number of subjects: 30
Study 17710657 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 28
Study 17710657 — intervention group
Group type: COMPARATOR
Intervention: Control (no amifostine)
Number of subjects: 28
Study 15001730 — intervention group
Group type: EXPERIMENTAL
Intervention: olanzapine plus divalproex
Number of subjects: 249
Study 15001730 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone plus divalproex
Number of subjects: 249
Study 15001730 — intervention group
Group type: COMPARATOR
Intervention: olanzapine plus placebo
Number of subjects: 249
Study 15001730 — intervention group
Group type: COMPARATOR
Intervention: risperidone plus placebo
Number of subjects: 249
Study 11341350 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions promoting mammography screening
Number of subjects: 0
Study 11341350 — intervention group
Group type: COMPARATOR
Intervention: Interventions targeting older women (minimum age, 50-65 years)
Number of subjects: 0
Study 11341350 — intervention group
Group type: COMPARATOR
Intervention: Interventions set in clinics
Number of subjects: 0
Study 9635220 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention aimed at reducing aggressive, disruptive behavior in first and second grades.
Number of subjects: 19
Study 9635220 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 19
Study 9635220 — intervention group
Group type: EXPERIMENTAL
Intervention: First grade boys' own aggressive behavior.
Number of subjects: 19
Study 9635220 — intervention group
Group type: EXPERIMENTAL
Intervention: First grade boys' poverty level.
Number of subjects: 19
Study 9635220 — intervention group
Group type: EXPERIMENTAL
Intervention: First grade girls' own aggressive behavior.
Number of subjects: 19
Study 7942080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal replacement therapy (HRT)
Number of subjects: 95
Study 7942080 — intervention group
Group type: COMPARATOR
Intervention: Oophorectomy (BSO) without HRT
Number of subjects: 95
Study 7942080 — intervention group
Group type: EXPERIMENTAL
Intervention: Oophorectomy (BSO) with HRT
Number of subjects: 95
Study 7942080 — intervention group
Group type: COMPARATOR
Intervention: Ovaries preserved and not receiving HRT
Number of subjects: 95
Study 7942080 — intervention group
Group type: COMPARATOR
Intervention: Continuous venous blood sampling before and after surgery
Number of subjects: 95
Study 2884551 — intervention group
Group type: COMPARATOR
Intervention: 0 glasses/d (control)
Number of subjects: 12
Study 2884551 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 glasses/d
Number of subjects: 12
Study 2884551 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 glasses/d
Number of subjects: 12
Study 2884551 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 glasses (binge drinking)
Number of subjects: 12
Study 29417987 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test
Number of subjects: 94
Study 29417987 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 94
Study 30151819 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended anticoagulation with vitamin K antagonists
Number of subjects: 743
Study 30151819 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 743
Study 30151819 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-risk group
Number of subjects: 743
Study 30151819 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 743
Study 30151819 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical score
Number of subjects: 743
Study 26574485 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 198
Study 26574485 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 198
Study 23708468 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) for one month
Number of subjects: 118
Study 23708468 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) for two months
Number of subjects: 118
Study 23708468 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) for four months
Number of subjects: 118
Study 23708468 — intervention group
Group type: COMPARATOR
Intervention: Standard psychosocial treatment
Number of subjects: 118
Study 21592879 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan 10/320 mg
Number of subjects: 834
Study 21592879 — intervention group
Group type: COMPARATOR
Intervention: Monotherapies (amlodipine 10 mg, valsartan 160 or 320 mg)
Number of subjects: 834
Study 21592879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 834
Study 21592879 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan
Number of subjects: 834
Study 21592879 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Amlodipine/valsartan)
Number of subjects: 834
Study 18355511 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Cox mini-Maze procedure using unipolar and bipolar radiofrequency systems
Number of subjects: 45
Study 18355511 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Cox mini-Maze procedure
Number of subjects: 45
Study 18355511 — intervention group
Group type: COMPARATOR
Intervention: Cox Maze III control group
Number of subjects: 45
Study 17030755 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial spin labeling (ASL) MRI in patients with FTD
Number of subjects: 70
Study 17030755 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal perfusion added to gray matter (GM) atrophy
Number of subjects: 70
Study 17030755 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal perfusion added to GM atrophy
Number of subjects: 70
Study 17030755 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining frontal and parietal lobe perfusion
Number of subjects: 70
Study 17030755 — intervention group
Group type: COMPARATOR
Intervention: Cognitively normal (CN) subjects
Number of subjects: 70
Study 12745039 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) 400 mg
Number of subjects: 74
Study 12745039 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (ACET) 1000 mg
Number of subjects: 74
Study 10857171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) mapping
Number of subjects: 0
Study 10857171 — intervention group
Group type: COMPARATOR
Intervention: Elective lymph node dissection (ELND)
Number of subjects: 0
Study 10857171 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic adjuvant therapy
Number of subjects: 0
Study 8623187 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - enoxaparin 40 mg/day
Number of subjects: 61
Study 8623187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 1452959 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective Patient Teaching course
Number of subjects: 30
Study 1452959 — intervention group
Group type: COMPARATOR
Intervention: Control group (no course)
Number of subjects: 30
Study 3006619 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (EN) 20 mg once-a-day
Number of subjects: 104
Study 3006619 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 104
Study 3006619 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 104
Study 31506396 — intervention group
Group type: COMPARATOR
Intervention: Ropinirole hydrochloride
Number of subjects: 0
Study 29757924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion (40 μg kg min over 5 min followed by 2.5 μg kg min)
Number of subjects: 121
Study 29757924 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline infusion (control group)
Number of subjects: 121
Study 29757924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 121
Study 25749689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid (ALIF at L5/S1 with total disc replacement at L4/5)
Number of subjects: 62
Study 25749689 — intervention group
Group type: COMPARATOR
Intervention: Fusion (2-level circumferential fusion with TLIF)
Number of subjects: 62
Study 25749689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid
Number of subjects: 62
Study 25749689 — intervention group
Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 62
Study 24287940 — intervention group
Group type: EXPERIMENTAL
Intervention: DEP 75 mg
Number of subjects: 174
Study 24287940 — intervention group
Group type: EXPERIMENTAL
Intervention: FEN 25 mg
Number of subjects: 174
Study 24287940 — intervention group
Group type: EXPERIMENTAL
Intervention: MZD 2 mg
Number of subjects: 174
Study 24287940 — intervention group
Group type: EXPERIMENTAL
Intervention: SIB 15 mg
Number of subjects: 174
Study 24287940 — intervention group
Group type: EXPERIMENTAL
Intervention: FXT 20 mg
Number of subjects: 174
Study 24287940 — intervention group
Group type: COMPARATOR
Intervention: PCB
Number of subjects: 174
Study 22408266 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued antidepressant treatment (63 patients)
Number of subjects: 128
Study 22408266 — intervention group
Group type: COMPARATOR
Intervention: Continuation of antidepressant treatment (68 patients)
Number of subjects: 128
Study 20814318 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 72
Study 20814318 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 72
Study 17728419 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive antidepressant use
Number of subjects: 335
Study 17728419 — intervention group
Group type: COMPARATOR
Intervention: Mood stabilizers alone (Control)
Number of subjects: 335
Study 15056426 — intervention group
Group type: EXPERIMENTAL
Intervention: Early resting myocardial perfusion gated-SPECT
Number of subjects: 222
Study 15056426 — intervention group
Group type: COMPARATOR
Intervention: Conventional management without gated-SPECT
Number of subjects: 222
Study 11703993 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 4632
Study 11703993 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 4632
Study 9881888 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (25, 50, 100 g)
Number of subjects: 8
Study 9881888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose (25, 50, 100 g)
Number of subjects: 8
Study 9881888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (25, 50 g)
Number of subjects: 8
Study 9881888 — intervention group
Group type: COMPARATOR
Intervention: White bread (25, 50, 100 g carbohydrate)
Number of subjects: 8
Study 8025071 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% nedocromil sodium
Number of subjects: 138
Study 8025071 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate
Number of subjects: 138
Study 8025071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 2554344 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathhold duration of 0 seconds
Number of subjects: 8
Study 2554344 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathhold duration of 10 seconds
Number of subjects: 8
Study 2554344 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathhold duration of 20 seconds
Number of subjects: 8
Study 1252350 — intervention group
Group type: EXPERIMENTAL
Intervention: White soft paraffin
Number of subjects: 0
Study 31252293 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy after extrapleural pneumonectomy
Number of subjects: 0
Study 28532935 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative computer‐assisted registration (Group 1)
Number of subjects: 52
Study 28532935 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative aberrometry (Group 2)
Number of subjects: 52
Study 24646076 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (0.07 mmol NO(3)(‐) /kg body weight/day; BR, n=11)
Number of subjects: 22
Study 24646076 — intervention group
Group type: COMPARATOR
Intervention: Control drink (CON, n=11)
Number of subjects: 22
Study 22672229 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 286
Study 22672229 — intervention group
Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 286
Study 21719896 — intervention group
Group type: EXPERIMENTAL
Intervention: Common TRPA1 haplotype defined by 1 missense and 10 intronic single nucleotide polymorphisms.
Number of subjects: 0
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar I disorder
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Delusional disorder
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depressive disorder (MDD), severe, with psychotic features
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychotic disorder
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotic disorder not otherwise specified (NOS)
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophreniform disorder
Number of subjects: 500
Study 19200422 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic changes
Number of subjects: 500
Study 15615749 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical induction of chorioretinal venous anastomosis (standard vitrectomy with choroidal incisions and Mersilene suture insertion)
Number of subjects: 28